Pyoderma gangrenosum in association with Janus kinase 2 (JAK2V617F) mutation
J A Palanivel1, A E Macbeth, N J Levell
1Department of Dermatology, Norfolk and Norwich University Hospital and NHS Trust, UK. drjananiap@gmail.com
Abstract:
Pyoderma gangrenosum (PG) commonly occurs in association with various haematological and inflammatory disorders. We report a new association, a Janus kinase (JAK)2 mutation, in a 63-year-old patient with PG. We hypothesise that PG occurs by direct activation of JAK along with signal transducers and activators of transcription (STAT), a common mechanism involved in the pathogenesis of inflammatory and haematological diseases.
Related Concept Videos
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Chronic Pancreatitis II: Pathophysiology
Acute Pancreatitis II: Pathophysiology
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Type I Diabetes II: Pathophysiology

